# US 2012/0058541 A1 · Engineering resistance to aliphatic alcohols

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0058541 A1
- Document ID: US20120058541A1
- Status: Published application
- Kind: A1
- Application number: 13/214,310
- Filed: 2011-08-22
- Published: 2012-03-08
- Earliest claimed: 2009-05-22
- Assignees: Butamax(Tm) Advanced Biofuels LLC
- Inventors: Keith Alsaker; Daniel Grenfell-Lee; Michael Hudson; Adam Lawrence; Jessica McGrath; David Young
- Web page: https://patentgrep.com/patent/US20120058541A1

## CPC

- C12N 9/52: derived from bacteria {or Archaea}
- C12P 7/16: Butanols
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

The present disclosure provides improved systems for the biological production of certain aliphatic alcohol compounds. In particular, the present disclosure provides biological systems that show improved resistance to aliphatic alcohol toxicity; in sonic embodiments, such improved resistance allows for increased levels of aliphatic alcohol production. Accordingly, the present disclosure provides, inter alia, engineered microorganisms that both produce an aliphatic alcohol compound and show resistance to that compound as measured by an ability to grow to predetermined levels in the presence of a given concentration of the compound.

## Claims

### Claim at position 1

1-294. (canceled)

### Claim 295

A recombinant microbial cell, characterized in that the recombinant microbial cell comprises at least one alcohol tolerance modification as compared with a parent cell.

### Claim 296 (depends on 1)

The recombinant microbial cell of claim 1, wherein the alcohol tolerance modification comprises introduction of a nucleic acid molecule comprising a 3′ region of a gene encoding a CAAX protease polypeptide.

### Claim 297 (depends on 296)

The recombinant microbial cell of claim 296, wherein the 3′ region of the gene comprises a 3′ untranslated region (UTR).

### Claim 298 (depends on 296)

The recombinant microbial cell of claim 296, wherein the 3′ region of the gene comprises nucleotides immediately downstream of sequence encoding the CAAX protease polypeptide.

### Claim 299 (depends on 296)

The recombinant microbial cell of claim 296, wherein the nucleic acid molecule comprises a 3′ region of a gene encoding a CAAX protease polypeptide in Lactobacillus.

### Claim 300 (depends on 299)

The recombinant microbial cell of claim 299, wherein the 3′ region of the gene comprises at least 10 consecutive nucleotides of the nucleotide sequence shown in Table 1B, row 42.

### Claim 301 (depends on 295)

The recombinant microbial cell of any of claim 295, wherein the alcohol tolerance modification comprises introduction of a nucleic acid molecule comprising a 5′ region of a gene encoding a CAAX protease polypeptide.

### Claim 302 (depends on 301)

The recombinant microbial cell of claim 301, wherein the 5′ region of the gene comprises a 5′ UTR.

### Claim 303 (depends on 301)

The recombinant microbial cell of claim 301, wherein the 5′ region of the gene comprises nucleotides immediately upstream of sequence encoding the CAAX protease polypeptide.

### Claim 304 (depends on 301)

The recombinant microbial cell of claim 301, wherein the nucleic acid molecule comprises a 5′ region of a gene encoding a CAAX protease polypeptide in Lactobacillus.

### Claim 305 (depends on 304)

The recombinant microbial cell of claim 304, wherein the 5′ region of the gene comprises at least 10 consecutive nucleotides of the nucleotide sequence shown in Table 1B, row 40.

### Claim 306 (depends on 295)

The recombinant microbial cell of any of claim 295, wherein the cell exhibits increased tolerance to at least one aliphatic alcohol compound as compared with the parent cell.

### Claim 307 (depends on 306)

The recombinant microbial cell of claim 306, wherein the increased tolerance to at least one aliphatic alcohol compound comprises an increased aliphatic alcohol compound IC50, wherein the IC50 is increased at least 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, or more.

### Claim 308 (depends on 306, 307)

The recombinant microbial cell of claim 306 or 307, wherein the increased tolerance to at least one aliphatic alcohol compound comprises increased carbohydrate utilization as compared to the parent cell when grown in same amount of alcohol.

### Claim 309 (depends on 308)

The recombinant microbial cell of claim 308, wherein the carbohydrate utilization is increased at least 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, or more.

### Claim 310 (depends on 295)

The recombinant cell of any of claim 295, wherein the cell exhibits increased alcohol production as compared with the parent cell.

### Claim 311 (depends on 295)

The recombinant microbial cell of any one of claim 295, wherein the cell is a member of a genus selected from the group consisting of Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Lactobacillus, Enterococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthrobacter, Corynebacterium, Brevibacterium, Acinetobacter, Pichia, Candida, Hansenula and Saccharomyces.
